|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leisching GR, Loos B, Botha MH and
Engelbrecht AM: The role of mTOR during cisplatin treatment in an
in vitro and ex vivo model of cervical cancer. Toxicology.
335:72–78. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yan HC, Fang LS, Xu J, Qiu YY, Lin XM,
Huang HX and Han QY: The identification of the biological
characteristics of human ovarian cancer stem cells. Eur Rev Med
Pharmacol Sci. 18:3497–3503. 2014.PubMed/NCBI
|
|
7
|
Yang CH, Wang HL, Lin YS, Kumar KP, Lin
HC, Chang CJ, Lu CC, Huang TT, Martel J, Ojcius DM, et al:
Identification of CD24 as a cancer stem cell marker in human
nasopharyngeal carcinoma. PLoS One. 9:e994122014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen YK, Huang AH and Lin LM:
Sphere-forming-like cells (squamospheres) with cancer stem-like
cell traits from VX2 rabbit buccal squamous cell carcinoma. Int J
Oral Sci. 6:212–738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ueda K, Ogasawara S, Akiba J, Nakayama M,
Todoroki K, Ueda K, Sanada S, Suekane S, Noguchi M and Matsuoka K:
Aldehyde dehydrogenase 1 identifies cells with cancer stem
cell-like properties in a human renal cell carcinoma cell line.
PLoS One. 8:e754632013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Batsaikhan BE, Yoshikawa K, Kurita N,
Iwata T, Takasu C, Kashihara H and Shimada M: Cyclopamine decreased
the expression of sonic hedgehog and its downstream genes in colon
cancer stem cells. Anticancer Res. 34:6339–6344. 2014.PubMed/NCBI
|
|
11
|
Peleg R, Romzova M, Kogan-Zviagin I, Apte
RN and Priel E: Modification of topoisomerases in mammospheres
derived from breast cancer cell line: Clinical implications for
combined treatments with tyrosine kinase inhibitors. BMC Cancer.
14:9102014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sassi Fde A, Caesar L, Jaeger M, Nör C,
Abujamra AL, Schwartsmann G, de Farias CB, Brunetto AL, Lopez PL
and Roesler R: Inhibitory activities of trichostatin a in U87
glioblastoma cells and tumor sphere-derived cells. J Mol Neurosci.
54:27–40. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Benko AL, Olsen NJ and Kovacs WJ: Estrogen
and telomerase in human peripheral blood mononuclear cells. Mol
Cell Endocrinol. 364:83–88. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Castillo V, Valenzuela R, Huidobro C,
Contreras HR and Castellon EA: Functional characteristics of cancer
stem cells and their role in drug resistance of prostate cancer.
Int J Oncol. 45:985–994. 2014.PubMed/NCBI
|
|
15
|
Huang Y, Ju B, Tian J, Liu F, Yu H, Xiao
H, Liu X, Liu W, Yao Z and Hao Q: Ovarian cancer stem cell-specific
gene expression profiling and targeted drug prescreening. Oncol
Rep. 31:1235–1248. 2014.PubMed/NCBI
|
|
16
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mannino M, Gomez-Roman N, Hochegger H and
Chalmers AJ: Differential sensitivity of glioma stem cells to
aurora kinase a inhibitors: Implications for stem cell mitosis and
centrosome dynamics. Stem Cell Res. 13:135–143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
O'Grady S, Finn SP, Cuffe S, Richard DJ,
O'Byrne KJ and Barr MP: The role of DNA repair pathways in
cisplatin resistant lung cancer. Cancer Treat Rev. 40:1161–1170.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chufan EE, Sim HM and Ambudkar SV:
Molecular basis of the polyspecificity of P-glycoprotein (ABCB1):
Recent biochemical and structural studies. Adv Cancer Res.
125:71–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Backos DS, Franklin CC and Reigan P: The
role of glutathione in brain tumor drug resistance. Biochem
Pharmacol. 83:1005–1012. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim JK, Jeon HY and Kim H: The molecular
mechanisms underlying the therapeutic resistance of cancer stem
cells. Arch Pharm Res. 38:389–401. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zinzi L, Contino M, Cantore M, Capparelli
E, Leopoldo M and Colabufo NA: ABC transporters in CSCs membranes
as a novel target for treating tumor relapse. Front Pharmacol.
5:1632014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wielgos M and Yang ES: Discussion of PARP
inhibitors in cancer therapy. Pharm Pat Anal. 2:755–766. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen T, Yang K, Yu J, Meng W, Yuan D, Bi
F, Liu F, Liu J, Dai B and Chen X: Identification and expansion of
cancer stem cells in tumor tissues and peripheral blood derived
from gastric adenocarcinoma patients. Cell Res. 22:248–258. 2012.
View Article : Google Scholar : PubMed/NCBI
|
